| Ytd | -30.62% | |
| 1y | 45.70% |
| Open | 11.16 | Prev Close | 11.25 | Low | 11.12 | High | 11.47 | Mkt Cap | 897.25M |
| Vol | 296.48K | Avg Vol | 1.23M | EPS | -1.47 | P/E | -7.65 | Forward P/E | 7.60 |
| Beta | 0.49 | Short Ratio | 9.36 | Inst. Own | 83.10% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 04-30 | 50-d Avg | 10.98 | 200-d Avg | 12.69 | 1yr Est | 23.70 |
Management to host conference call on Thursday, July 30, 2026, at 8:00 am EDT Management to host con
Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT), a biopharmaceutical company focused on developing and c
Top Wall Street analysts upgraded PHAT and PWR, while AGX was upgraded to Overweight with a $550 pri
During Monday's trading, 1214 companies set new 52-week lows.